Seoul Pharma Co., Ltd (KOSDAQ:018680)

Seoul Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	33,987	35,911	38,592	44,655	58,646	66,918
Market Cap Growth	-10.17%	-6.95%	-13.58%	-23.86%	-12.36%	-28.31%
Enterprise Value	41,430	46,093	44,514	45,715	75,292	82,364
Last Close Price	2915.00	3080.00	3310.00	3830.00	5030.00	7850.00
PE Ratio	45.10	47.65	22.72	12.70	68.58	-
PS Ratio	0.65	0.69	0.72	0.85	1.17	1.65
PB Ratio	0.83	0.88	0.96	1.16	1.66	3.53
P/TBV Ratio	0.84	0.89	0.98	1.18	1.70	3.70
P/FCF Ratio	33.17	35.05	-	13.24	-	-
P/OCF Ratio	18.02	19.04	-	8.48	-	-
EV/Sales Ratio	0.79	0.88	0.83	0.87	1.50	2.04
EV/EBITDA Ratio	29.96	33.34	11.08	14.56	17.30	-
EV/EBIT Ratio	-	-	29.14	37.70	43.30	-
EV/FCF Ratio	40.44	44.99	-	13.56	-	-
Debt / Equity Ratio	0.42	0.42	0.40	0.28	0.42	1.55
Debt / EBITDA Ratio	12.58	12.58	4.01	3.49	3.43	-
Debt / FCF Ratio	16.98	16.98	-	3.25	-	-
Net Debt / Equity Ratio	0.18	0.18	0.21	0.03	0.09	0.82
Net Debt / EBITDA Ratio	5.38	5.38	2.14	0.41	0.74	-4.89
Net Debt / FCF Ratio	7.27	7.27	-1.64	0.38	-2.45	-5.50
Asset Turnover	0.73	0.73	0.79	0.83	0.80	0.64
Inventory Turnover	1.75	1.75	1.81	2.10	2.29	2.15
Quick Ratio	1.51	1.51	1.20	0.72	1.20	0.64
Current Ratio	2.28	2.28	2.28	1.25	1.87	0.86
Return on Equity (ROE)	1.86%	1.86%	4.32%	9.51%	3.15%	-40.53%
Return on Assets (ROA)	-1.11%	-1.11%	1.42%	1.21%	1.74%	-5.61%
Return on Invested Capital (ROIC)	-2.56%	-2.63%	3.33%	2.69%	4.75%	-15.14%
Return on Capital Employed (ROCE)	-2.30%	-2.30%	2.70%	2.80%	3.60%	-17.10%
Earnings Yield	2.22%	2.10%	4.40%	7.88%	1.46%	-14.48%
FCF Yield	3.01%	2.85%	-13.57%	7.55%	-2.24%	-4.23%
Buyback Yield / Dilution	-	-	-	-29.84%	-5.34%	-0.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.